Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer's disease areas.
97 employees · est. 2018 · New York, United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
7 employees · est. 2016 · San Diego, United States
Locanabio, Inc. is the older company (2018 vs 2016); Lexeo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Lexeo Therapeutics | Locanabio, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | New York, United States | San Diego, United States |
| Employees | ||
| Employees | 97 larger | 7 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series B |
| Total Funding | ||
| Total Funding | $280.00M | $155.55M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Genetic Medicine, Clinical-stage, Gene Therapy, Rare Diseases, Cardiovascular Diseases, Alzheimer's Disease, AAV-mediated Therapies, Weill Cornell Medicine, University Of California San Diego, New York City, Research Collaboration, Commercialization, Preclinical Pipeline, Innovation | RNA-targeting Gene Therapy, Genetic Medicine, Neurodegenerative Diseases, Neuromuscular Diseases, Rare Genetic Diseases, RNA Biology, Gene Editing, Genomic Medicine, RNA-mediated Disease, Drug Development, Neurological Disorders |
| Website | ||
| Website | lexeotx.com | locanabio.com |
About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based biotechnology startup that is making waves in the field of genetic medicines. The company is on a mission to revolutionize healthcare by leveraging cutting-edge science to change the way diseases are treated. Its focus areas include cardiovascular and APOE...
About Locanabio, Inc.
Locanabio, Inc., founded in 2016, is at the forefront of developing RNA-targeting gene therapies to address significant unmet medical needs. Their innovative approach focuses on correcting disease-causing RNA, utilizing a proprietary platform that includes advanced systems like snRNA, Cas13d, and PU...
We will tell you when either one moves
BounceWatch watches Lexeo Therapeutics and Locanabio, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Lexeo Therapeutics and Locanabio, Inc. — by email.
Frequently Asked Questions
Compare Lexeo Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Lexeo Therapeutics on 9 Jun 2026, and Locanabio, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
